Table 1 Characteristics of the patient populations used for the initial application of the self-efficacy instruments
Instrument | First author, year [reference number] | Full name | Country | Sample size | Cancer types | Mean age (years) | % female | % high school or above | Year since diagnosis(years) | Treatment(stage& type) |
|---|---|---|---|---|---|---|---|---|---|---|
SICPA | Telch, 1986 [16] | The Standford Inventory of Cancer Patient Adjustment | USA | 41 | Mixed | 18~65 | NR | NR | NR | NR |
SUPPH | Lev et, 1996 [13] | Strategies Used by People to Promote Health | USA | 178 | Mixed | 53.6 ± 13.55 | 61% | 84% | NR | Chemo |
SEAC | Hirai, 2001 [26] | The Self-Efficacy scale for Advanced Cancer | Japan | 50 | Mixed terminal | 60.8 ± 9.6 | 60% | NR | NR | NR |
SESCI | Porter et al.,2002[15] | Self-Efficacy for Symptom Control Inventory | USA | 30 | Lung | 62.5 ± 10.7 | 40% | NR | NR | NR |
CASE-cancer | Wolf,2005 [20] | The Communication and Attitudinal Self-Efficacy for cancer | USA | 136 | Mixed | 63.3 ± 15.0 | 15.2% | 53.8% | NR | NR |
OTSES-CA | Liang,2008 [23] | Opioid-Taking Self-Efficacy Scale-Cancer | China | 92 | Mixed | 56.4 ± 12.2 | 41% | NR | NR | NR |
CBI-B | Heitzmann, 2011 [17] | The brief version of Cancer Behavior Inventory | USA | 1304 | Mixed | 62 | 71% | 41%~ 94% | NR | NR |
PSEFSM | Hofffman,2011 [18] | Perceived Self-Efficacy for Fatigue Self-Management instrument | USA | 298 | Mixed | Age ≥ 21 | 70% | 90% | NR | Chemo +/− XRT |
SESSM-B | Lee,2012 [24] | Self-Efficacy Scale for Self-Management of Breast cancer | Korea | 303 | Breast | 47.7 ± 8.7 | 100% | 78.9% | 3.4 ± 3.6 | 53.8% during tx 46.2% post tx 21.5% surgery, 27% XRT 52.8% chemo 3.7% hormone |
BCSES | Champion,2013 [25] | Breast Cancer Survivor Self-efficacy Scale | USA | 1127 | Breast | 57.1 ± 11.6 | 100% | 97% | 5.9 ± 1.5 | Post-chemo |
C-SUPPH | Yuan,2014 [14] | Strategies Used by People to Promote Health-Chinese version | China | 764 | Mixed | 54.03 ± 5.13 | 50.8% | NR | NR | 31% surgery + chemo |
EBSES | Buchan et al., 2015 [22] | Exercise barriers self-efficacy scale | Australia | 101 | Mixed | 59.6/56.3 | 92.6%/ 100% | NR | NR | NR |
SMSES-BC | Liang, 2015 [8] | Symptom-management self-efficacy scale for breast cancer related to chemotherapy | China | 152 | Breast | 54.3 ± 9.9 | 100% | 75.7% | 4.2 ± 5.4 | 65.2% chemo 37.6% hormone 24.9% target |
SMSFS-A | Chan, 2016 [19] | Self-efficacy in managing symptoms Scale-Fatigue Subscale for Patients With Advanced Cancer | Australia | 10 | Mixed advanced cancer | 62.6 ± 9.1 | 90% | 70% | NR | 10% XRT 10% chemo+XRT 10% target |
SESPRM-LC | Huang et al., 2017 [21] | Self-efficacy scale for rehabilitation management designed specifically for postoperative lung cancer patients | China | 448 | Lung cancer | 58.37 ± 9.9 | 39.6% | 29.7% | NR | Surgery |